BioTechniques · 2005 · 116 citations · 14 references
Life SciencesBiochemistryPathologyMass Spectrometric AnalysisProtein BiochemistryProteomicsMass Spectrometry-based ProteomicsPeptide AnalysisProtein IdentificationProtein QuantificationProteomic BiomarkersProteomic ProfilingLiquid Biopsy ProteomicsMass Spectrometry ProteomicsMass Spectrometry-based Protein IdentificationPeptide Mass SpectrometryPeptide-mass FingerprintingProtein Mass SpectrometryProteomic Biomarker ValidationProteomic Identification
Identification and quantitation of candidate biomarker proteins in large numbers of individual tissues is required to validate specific proteins, or panels of proteins, for clinical use as diagnostic, prognostic, toxicological, or therapeutic markers. Mass spectrometry (MS) provides an exciting analytical methodology for this purpose. Liquid Tissue MS protein preparation allows researchers to utilize the vast, already existing, collections offormalin-fixed paraffin-embedded (FFPE) tissues for the procurement of peptides and the analysis across a variety of MS platforms.
14
Use of proteomic patterns in serum to identify ovarian cancer
Emanuel F. Petricoin, Ali M. Ardekani, Ben A. Hitt et al. · The Lancet · 2002 · 3.3K citations
Medicine, Gynecology, Oncology +17